26887049|t|Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport.
26887049|a|Pirinixic acid derivatives, a new class of drug candidates for a range of diseases, interfere with targets including PPARalpha, PPARgamma, 5-lipoxygenase (5-LO), and microsomal prostaglandin and E2 synthase-1 (mPGES1). Since 5-LO, mPGES1, PPARalpha, and PPARgamma represent potential anti-cancer drug targets, we here investigated the effects of 39 pirinixic acid derivatives on prostate cancer (PC-3) and neuroblastoma (UKF-NB-3) cell viability and, subsequently, the effects of selected compounds on drug-resistant neuroblastoma cells. Few compounds affected cancer cell viability in low micromolar concentrations but there was no correlation between the anti-cancer effects and the effects on 5-LO, mPGES1, PPARalpha, or PPARgamma. Most strikingly, pirinixic acid derivatives interfered with drug transport by the ATP-binding cassette (ABC) transporter ABCB1 in a drug-specific fashion. LP117, the compound that exerted the strongest effect on ABCB1, interfered in the investigated concentrations of up to 2muM with the ABCB1-mediated transport of vincristine, vinorelbine, actinomycin D, paclitaxel, and calcein-AM but not of doxorubicin, rhodamine 123, or JC-1. In silico docking studies identified differences in the interaction profiles of the investigated ABCB1 substrates with the known ABCB1 binding sites that may explain the substrate-specific effects of LP117. Thus, pirinixic acid derivatives may offer potential as drug-specific modulators of ABCB1-mediated drug transport. 
26887049	30	44	pirinixic acid	Chemical	MESH:C006253
26887049	60	65	ABCB1	Gene	5243
26887049	91	105	Pirinixic acid	Chemical	MESH:C006253
26887049	208	217	PPARalpha	Gene	5465
26887049	219	228	PPARgamma	Gene	5468
26887049	230	244	5-lipoxygenase	Gene	240
26887049	246	250	5-LO	Gene	240
26887049	301	307	mPGES1	Gene	9536
26887049	316	320	5-LO	Gene	240
26887049	322	328	mPGES1	Gene	9536
26887049	330	339	PPARalpha	Gene	5465
26887049	345	354	PPARgamma	Gene	5468
26887049	380	386	cancer	Disease	MESH:D009369
26887049	440	454	pirinixic acid	Chemical	MESH:C006253
26887049	470	485	prostate cancer	Disease	MESH:D011471
26887049	487	491	PC-3	CellLine	CVCL:0035
26887049	497	510	neuroblastoma	Disease	MESH:D009447
26887049	512	520	UKF-NB-3	CellLine	CVCL:9904
26887049	608	621	neuroblastoma	Disease	MESH:D009447
26887049	652	658	cancer	Disease	MESH:D009369
26887049	753	759	cancer	Disease	MESH:D009369
26887049	787	791	5-LO	Gene	240
26887049	793	799	mPGES1	Gene	9536
26887049	801	810	PPARalpha	Gene	5465
26887049	815	824	PPARgamma	Gene	5468
26887049	843	857	pirinixic acid	Chemical	MESH:C006253
26887049	908	928	ATP-binding cassette	Gene	10058
26887049	930	933	ABC	Gene	10058
26887049	947	952	ABCB1	Gene	5243
26887049	981	986	LP117	Chemical	-
26887049	1038	1043	ABCB1	Gene	5243
26887049	1114	1119	ABCB1	Gene	5243
26887049	1142	1153	vincristine	Chemical	MESH:D014750
26887049	1155	1166	vinorelbine	Chemical	MESH:D000077235
26887049	1168	1181	actinomycin D	Chemical	MESH:D003609
26887049	1183	1193	paclitaxel	Chemical	MESH:D017239
26887049	1199	1209	calcein-AM	Chemical	MESH:C085925
26887049	1221	1232	doxorubicin	Chemical	MESH:D004317
26887049	1234	1247	rhodamine 123	Chemical	MESH:D020112
26887049	1252	1256	JC-1	Chemical	MESH:C068624
26887049	1355	1360	ABCB1	Gene	5243
26887049	1387	1392	ABCB1	Gene	5243
26887049	1458	1463	LP117	Chemical	-
26887049	1471	1485	pirinixic acid	Chemical	MESH:C006253
26887049	1549	1554	ABCB1	Gene	5243
26887049	Association	MESH:C006253	5243
26887049	Negative_Correlation	MESH:C006253	MESH:D011471
26887049	Association	MESH:C006253	9536
26887049	Association	MESH:C006253	5465
26887049	Association	MESH:D014750	5243
26887049	Association	MESH:C006253	5468
26887049	Association	MESH:C006253	240
26887049	Association	MESH:D017239	5243
26887049	Association	MESH:C085925	5243
26887049	Association	MESH:D000077235	5243
26887049	Association	MESH:C006253	10058
26887049	Association	MESH:D003609	5243
26887049	Association	MESH:D009447	5243

